Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

6986 results

Sort By:

A Study of Botensilimab and Balstilimab for Rectal Adenocarcinoma

Study ID: NCT06843434
Start Date: 2025-02-20
End Date: 2028-02-20
Study Type

Interventional

Study Phase

Phase2

No. of Participants

40

Intervention / Treatment

Balstilimab

Botensilimab

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Study ID: NCT05983432
Start Date: 2023-08-08
End Date: 2028-03-21
Study Type

Interventional

Study Phase

Phase1

No. of Participants

260

Intervention / Treatment

BL-B01D1

Sponsor

SystImmune Inc.

Source: clinicaltrials.gov

Share:
Add to list

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Study ID: NCT07228832
Start Date: 2025-11-15
End Date: 2029-11-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

600

Intervention / Treatment

Drug: Ivonescimab Injection

Drug: Bevacizumab Injection

Sponsor

Summit Therapeutics

Source: clinicaltrials.gov

Share:
Add to list

Efficacy of Perioperative Opioid Sparing Techniques on Time to Initiation of Chemotherapy

Study ID: NCT07153614
Start Date: 2025-02-03
End Date: 2027-02-03
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Intrathecal Morphine Block

Bilateral Square Lumbar Block

Bilateral Transverse Abdominis Plane Block

Sponsor

University of Tennessee Graduate School of Medicine

Source: clinicaltrials.gov

Share:
Add to list

Study of AZD0754 in Participants With Metastatic Prostate Cancer

Study ID: NCT06267729
Start Date: 2024-03-12
End Date: 2026-11-24
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

AZ0754

More and more

Sponsor

AstraZeneca

Source: clinicaltrials.gov

Share:
Add to list

A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma

Study ID: NCT04936529
Start Date: 2021-08-02
End Date: 2026-06-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

286

Intervention / Treatment

β-glucan

GM-CSF

OPT-821

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study

Study ID: NCT04641247
Start Date: 2021-04-16
End Date: 2026-11-13
Study Type

Interventional

Study Phase

Phase2

No. of Participants

30

Intervention / Treatment

absolute

Sponsor

GlaxoSmithKline

Source: clinicaltrials.gov

Share:
Add to list

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

Study ID: NCT07217171
Start Date: 2025-11-13
End Date: 2031-01-29
Study Type

Interventional

Study Phase

Phase1

No. of Participants

160

Intervention / Treatment

EVOLVE104

EVOLVE104

Sponsor

EvolveImmune United, Inc

Source: clinicaltrials.gov

Share:
Add to list

Impact of RFA on Esophageal Distensibility and Mucosal Impedance

Study ID: NCT07126535
Start Date: 2025-08-19
End Date: 2027-07
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

10

Intervention / Treatment

Radiofrequency ablation alone

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

Study ID: NCT05870579
Start Date: 2023-11-13
End Date: 2032-01-26
Study Type

Interventional

Study Phase

Phase1

No. of Participants

48

Intervention / Treatment

Yu68GashGa-Neob

[177 Lu] Lu-NeoB

Ribociclib

Fulvestrant

Goserelin

Sponsor

Novartis Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list